Literature DB >> 24235852

Clinical indicators for severe prognosis of scrub typhus.

Pamornsri Sriwongpan1, Pornsuda Krittigamas, Pacharee Kantipong, Naowarat Kunyanone, Jayanton Patumanond, Sirianong Namwongprom.   

Abstract

BACKGROUND: The study explored clinical risk characteristics that may be used to forecast scrub typhus severity under routine clinical practices.
METHODS: Retrospective data were collected from patients registered at two university-affiliated tertiary care hospitals in the north of Thailand, from 2004 to 2010. Key information was retrieved from in-patient records, out patient cards, laboratory reports and registers. Patients were classified into three severity groups: nonsevere, severe (those with at least one organ involvement), and deceased. Prognostic characteristics for scrub typhus severity were analyzed by a multivariable ordinal continuation ratio regression.
RESULTS: A total of 526 patients were classified into nonsevere (n = 357), severe (n = 100), and deceased (n = 69). The significant multivariable prognostic characteristics for scrub typhus severity were increased body temperature (odds ratio [OR] = 0.58, 95% confidence interval [CI] = 0.45-0.74, P < 0.001), increased pulse rate (OR = 1.03, 95% CI = 1.01-1.05, P < 0.001), presence of crepitation (OR = 3.25, 95% CI = 1.52-6.96, P = 0.001), increased percentage of lymphocytes (OR = 0.97, 95% CI = 0.95-0.98, P = 0.001), increased aspartate aminotransferase (every 10 IU/L) (OR = 1.04, 95% CI = 1.02-1.06, P < 0.001), increased serum albumin (OR = 0.47, 95% CI = 0.27-0.80, P = 0.001), increased serum creatinine (OR = 1.83, 95% CI = 1.50-2.24, P < 0.001), and increased levels of positive urine albumin (OR = 1.43, 95% CI = 1.17-1.75, P < 0.001).
CONCLUSION: Patients suspicious of scrub typhus with low body temperature, rapid pulse rate, presence of crepitation, low percentage of lymphocyte, low serum albumin, elevated aspartate aminotransferase, elevated serum creatinine, and positive urine albumin should be monitored closely for severity progression.

Entities:  

Keywords:  complications; rickettsial infection; risk factors; severe scrub typhus

Year:  2013        PMID: 24235852      PMCID: PMC3826289          DOI: 10.2147/RMHP.S52470

Source DB:  PubMed          Journal:  Risk Manag Healthc Policy        ISSN: 1179-1594


Introduction

Scrub typhus, an infectious disease caused by Orientia tsutsugamushi from chigger bites, is common in Asia-Pacific countries.1 In Thailand, there were 7,310 cases in 2011 and 9,000 cases in 2012, most prevalent in the northern region.2 An infected person may show only low grade fever, which disappears in a few days, or severe manifestations caused by complications of various organs in the second week. Pneumonia, acute respiratory distress syndrome, myocarditis, liver failure, acute renal failure, encephalitis, and shock from focal vasculitis and perivasculitis are some examples. Severe complications were reported in 2%–36% of cases and were associated with organ involvement, different serotype, and patient immunity. Severe complications may cause death, and mortality reports, which may be as high as 30% without proper treatment, varied from place to place.3–10 An indirect immunofluorescence antibody test is the standard diagnostic test, but other methods, such as the indirect immunoperoxidase test and the polymerase chain reaction test, were developed later and are also used. However, these tests are still considered expensive in countries with limited health care resources. They require well-equipped laboratory settings, trained personnel, and may take many days to many weeks to provide results.1,11,12 The cheaper Weil–Felix test is, therefore, still used in the general hospitals of some countries; however, it has low sensitivity and specificity.7,12 The rapid immunochromatographic test is therefore used to help in making prompt treatment decisions in those countries, including Thailand. To make the test more specific, some countries developed their own tests utilizing the prevalent serotypes.12 In routine clinical practice, the disease is diagnosed from clinical signs and symptoms, the history of contact, and the initial laboratory tests in order to start treatment. Patients respond rapidly with early diagnosis and treatment, but when the diagnosis and treatment are delayed, complications are common and death may follow.3–5,13–15 Studies of risk factors for severe scrub typhus and/or death reported somewhat similar results: mainly they include abnormalities of laboratory findings such as leukocytosis, thrombocytopenia, hyperbilirubinemia, hypoalbuminemia, elevated transaminase, serum creatinine levels and abnormal chest X-ray. Nonlaboratory risk factors related to severity were headache, presence of eschar, and age more than 60 years.5,7,13 The present study aims to explore clinical risk characteristics that may be used to forecast disease severity under routine clinical practice. The findings may be incorporated into clinical evaluation, awareness, and prevention of disease complications, which may reduce case fatality.

Material and methods

Patients

Patients were those diagnosed with scrub typhus, registered in two university-affiliated tertiary care hospitals in Chiang Rai and Chiang Mai, in the north of Thailand, from 2004 to 2010. The guidelines for diagnosis used by the two hospitals followed the modified World Health Organization recommended surveillance standards (Table 1).9 Patients were categorized into three groups by their severity: (1) nonsevere, those without any complications; (2) severe, those with at least one organ involvement (Table 2); and (3) deceased, those who died of scrub typhus or complications following scrub typhus in the present admission. Patients were not included in the study if their discharge status was not stated, or if they were enrolled in another parallel study (a clinical trial on steroid treatment).
Table 1

Operational definitions of scrub typhus based on the World Health Organization

Patients with bothAccompanied by at least oneAlso accompanied with at least one
Exposed to chiggers (stayed or went into risk areas within 2 weeks before the onset of symptoms)HeadachePresence of eschar
MyalgiaPositive immunochromatographic test for scrub typhus
Profuse sweating
Cough
Conjunctival injection
Reported acute fever (within 2 weeks of onset of symptoms)
Lymphadenopathy
Maculopapular rash

Note: Copyright © 2013. World Health Organization (WHO)2013. Reproduced with permission World Health Organization. WHO recommended surveillance standards. 2004: 123–124. Available from: http://www.who.int/csr/resources/publications/surveillance/whocdscsrisr992.pdf. Accessed on July 21, 2013.9

Table 2

Definitions of severe scrub typhus

System involvementCharacteristics
Cardiovascular systemPresence of any of the following: Systolic blood pressure <90 mmHg
Abnormal cardiac arrhythmia with no previous history of the following:
 1. atrial fibrillation;
 2. supraventricular tachycardia;
 3. frequent premature ventricular tachycardia.
Myocarditis: elevated CK-MB above base line.
Respiratory systemPresence of acute respiratory distress syndrome, defined as follows:
 1. PaO2/FiO2 (mmHg) <200 in room air;
 2. with bilateral interstitial infiltration on chest X-ray;
 3. with normal cardio/thoracic ratio or no volume overload of CVP from central venous catheter.
Central nervous systemPresence of any of the following:
 1. GCS ≤12 without other causes;
 2. seizure without other causes;
 3. meningoencephalitis.
HematologyPlatelet count ≤20,000/mL
Urinary tractPresence of acute renal failure defined as any of the following;
 1. Creatinine ≥2 mg/dL
 2. Creatinine change >0.5 mg/dL/day
Gastrointestinal tractPresence of hepatitis, as defined by the following:
 1. elevated aspartate aminotransferase;
 2. or alanine aminotransferase more than five-fold above baseline.

Note: Adapted from Chiang Rai Prachanukroh Hospital expert agreements on categorizing scrub typhus severity (with permission).

Abbreviations: CK-MB, myocardial muscle creatine kinase; CVP, central venous pressure; GCS, Glasgow Coma Scale; PaO2/FiO2, ratio of partial pressure arterial oxygen and fraction of inspired oxygen.

Data collection

Retrospective data were used, and key information was retrieved from in-patient medical files, out patient cards, laboratory reports and registers.

Study characteristics

All of the following study characteristics were examined within the first day of admission: Demographic data: sex, age, underlying disease (diabetes, hypertension, chronic obstructive pulmonary disease, and liver cirrhosis). Clinical manifestations: headache, myalgia, cough, nausea, vomiting, abdominal pain, diarrhea, conjunctival injection, jaundice, eschar, maculopapular rash, lymphadenopathy, hepatomegaly, splenomegaly, stiff neck, seizure, crepitation, wheezing, and dyspnea. Vital signs: body temperature (°C), systolic blood pressure (mmHg), diastolic blood pressure (mmHg), pulse (beats per minute), and respiration (breaths per minute). Laboratory findings: hematological tests, liver function tests, renal function tests, electrolyte profiles, urine albumin, and urine glucose.

Data analysis

The different characteristics across the three groups were tested by using nonparametric trend testing across ordered groups. The characteristics related to disease severity (presented with odds ratios [OR]) were explored and tested with multivariable ordinal continuation ratio logistic regression. Type 1 errors were set at ≤0.001.

Ethics statement

The study was approved by Chiang Rai Prachanukroh Hospital Ethics Committee for Research, the Ethics Committee for Research, Nakornping Hospital, and the Ethical Committee on Research in Patients, Faculty of Medicine, Chiang Mai University. All traceable individual data were kept confidential throughout all processes of analysis.

Results

A total of 526 eligible cases of scrub typhus were classified into nonsevere (n = 357), severe (n = 100), and deceased (n = 69). They were similar in sex, underlying disease, myalgia, cough, nausea/vomiting, abdominal pain, conjunctival injection, eschar, maculopapular rash, hepatomegaly, splenomegaly, respiration rate, hematocrit, hemoglobin, globulin, potassium, and chloride (Tables 3 and 4).
Table 3

Demographic characteristics and clinical manifestations of patients with scrub typhus (n = 526)

CharacteristicsNonsevere (n = 357)Severe (n = 100)Deceased (n = 69)P-value
Demographics
Male201 (56.3)55 (55.0)35 (50.7)0.413
Age (years)25.0 ± 20.632.6 ± 21.846.7 ± 20.2<0.001
Underlying diseases30 (8.4)14 (14.0)8 (11.6)0.186
Clinical manifestations
Headache117 (32.8)29 (29.0)14 (20.3)0.041
Myalgia69 (19.3)23 (23.0)13 (18.8)0.820
Cough120 (33.6)32 (32.0)17 (24.6)0.172
Nausea, vomiting83 (23.3)27 (27.0)12 (19.4)0.544
Abdominal pain118 (33.1)35 (35.0)25 (36.2)0.565
Diarrhea60 (16.8)25 (25.0)17 (24.6)0.047
Conjunctival injection330 (92.4)90 (90.0)64 (92.8)0.823
Jaundice11 (3.1)21 (21.0)17 (24.6)<0.001
Eschar192 (53.8)60 (60.0)38 (55.1)0.557
Maculopapular rash324 (90.8)95 (95.0)66 (95.7)0.086
Lymphadenopathy237 (66.4)73 (73.0)63 (91.0)<0.001
Hepatomegaly113 (31.7)36 (36.0)14 (20.3)0.198
Splenomegaly40 (11.2)9 (9.0)4 (5.8)0.157
Stiff neck6 (1.7)4 (4.0)4 (5.8)0.032
Seizure4 (1.1)10 (10.0)12 (17.4)<0.001
Crepitation13 (3.6)18 (18.0)25 (36.2)<0.001
Wheezing2 (0.6)6 (6.0)7 (10.1)<0.001
Dyspnea7 (1.9)7 (7.0)25 (36.2)<0.001
Vital signs
Body temperature (°C)38.5 ± 1.138.0 ± 1.237.5 ± 0.9<0.001
SBP (mmHg)105.8 ± 14.195.9 ± 19.899.9 ± 23.9<0.001
DBP (mmHg)65.7 ± 9.558.8 ± 13.660.2 ± 16.5<0.001
Pulse (beats/min)103 ± 21.3104 ± 22.5109.2 ± 24.70.049
Respiration (breaths/min)25.2 ± 8.827.4 ± 10.723.5 ± 3.90.058

Notes: Values are n (%) or mean ± SD; P-values are from nonparametric trend testing across ordered groups.

Abbreviations: DBP, diastolic blood pressure; SBP, systolic blood pressure; SD, standard deviation.

Table 4

Laboratory findings in patients with scrub typhus (n = 526)

CharacteristicsNonsevere (n = 357)Severe (n = 100)Deceased (n = 69)P-value
Hematological
WBC (×1000/mm3)8.9 ± 4.911.4 ± 5.412.7 ± 6.0<0.001
Platelet (×1000/mm3)150.0 ± 107.7111.9 ± 110.776.6 ± 76.1<0.001
Hematocrit (%)35.2 ± 6.334.3 ± 5.436.2 ± 6.80.805
Hemoglobin (gm%)11.9 ± 2.111.5 ± 1.812.1 ± 2.30.999
Neutrophil (%)66.4 ± 16.377.3 ± 15.079.5 ± 17.4<0.001
Lymphocyte (%)24.7 ± 14.714.7 ± 11.711.6 ± 12.7<0.001
Monocyte (%)6.6 ± 7.45.0 ± 8.45.3 ± 8.2<0.001
Liver function
ALT (IU/L)94.5 ± 94.5121.5 ± 102.2253.7 ± 606.80.001
AST (IU/L)134.4 ± 103.3207.6 ± 164.6804.0 ± 2,289.3<0.001
ALP (IU/L)217.6 ± 154.5333.1 ± 273.5266.9 ± 155.5<0.001
Total bilirubin (mg/dL)1.3 ± 1.73.9 ± 4.75.9 ± 7.9<0.001
Direct bilirubin (mg/dL)0.5 ± 1.02.1 ± 2.43.4 ± 3.9<0.001
Albumin (g/dL)3.2 ± 0.62.7 ± 0.52.6 ± 0.5<0.001
Globulin (g/dL)3.3 ± 0.73.1 ± 0.73.3 ± 0.70.199
Renal function
BUN (mg/dL)15.5 ± 12.138.0 ± 28.355.0 ± 34.0<0.001
Creatinine (mg/dL)1.1 ± 0.82.1 ± 1.83.5 ± 3.1<0.001
Electrolyte profile
Na (mmol/L)133.8 ± 3.9132.6 ± 5.2132.6 ± 6.10.034
K (mmol/L)3.5 ± 0.53.6 ± 0.63.8 ± 0.90.060
Cl2 (mmol/L)101.1 ± 4.6100.6 ± 6.2100.0 ± 7.70.365
CO2 (mmol/L)22.8 ± 3.720.2 ± 4.516.4 ± 5.0<0.001
Urine albumin
Negative132 (44.4)25 (29.4)7 (1.5)<0.001
Trace58 (19.5)15 (17.7)5 (8.2)
1+49 (16.5)17 (20.0)10 (16.4)
2+45 (15.2)24 (28.2)20 (32.8)
3+13 (4.4)4 (4.7)16 (28.2)
4+0 (0)0 (0)3 (4.9)
Urine glucose
Negative276 (92.9)78 (91.7)48 (78.7)0.002
Trace16 (5.4)6 (7.1)11 (18.0)
1+1 (0.3)0 (0)1 (1.6)
2+1 (0.3)1 (1.2)0 (0)
3+3 (1.0)0 (0)0 (0)
4+0 (0)0 (0)1 (1.6)

Notes: Values are n (%) or mean ± SD. For urine albumin, trace is 5–20 mg/dL; 1+, 30 mg/dL; 2+, 100 mg/dL; 3+, 300 mg/dL; 4+, 2,000 mg/dL. For urine glucose, trace is 100 mg/dL; 1+, 250 mg/dL; 2+, 500 mg/dL; 3+, 1,000 mg/dL; 4+, 2,000 mg/dL.

Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urine nitrogen; Cl2, chloride; CO2, carbon dioxide; K, potassium; Na, sodium; SD, standard deviation; WBC, white blood cell.

Different characteristics across groups were age, headache, diarrhea, jaundice, lymphadenopathy, stiff neck, seizure, crepitation, wheezing, dyspnea, vital signs (body temperature, systolic blood pressure, diastolic blood pressure, pulse rate), hematological tests (white blood cell count, platelet count, neutrophils, lymphocytes, monocytes), liver function tests (aspartate aminotransferase [AST], alanine aminotransferase, alkaline phosphatase, total bilirubin, direct bilirubin, albumin), renal function test (blood urea nitrogen, creatinine), electrolyte profiles (sodium, carbon dioxide), and urine examinations (urine albumin, urine glucose) (Tables 3 and 4). Under the multivariable ordinal continuation ratio logistic regression, the characteristics related to disease severity were increased body temperature (OR = 0.58, 95% confidence interval [CI] = 0.45–0.74, P < 0.001), increased pulse rate (OR = 1.03, 95% CI = 1.01–1.05, P < 0.001), presence of crepitation (OR = 3.25, 95% CI = 1.52–6.96, P = 0.001), increased percentage of lymphocytes (OR = 0.97, 95% CI = 0.95–0.98, P = 0.001), increased AST (every 10 IU/L) (OR = 1.04, 95% CI = 1.02–1.06, P < 0.001), increased serum albumin (OR = 0.47, 95% CI = 0.27–0.80, P = 0.001), increased serum creatinine (OR = 1.83, 95% CI = 1.50–2.24, P < 0.001), and increased levels of positive urine albumin (OR = 1.43, 95% CI = 1.17–1.75, P < 0.001) (Table 5).
Table 5

Multivariable analysis of prognostic indicators for scrub typhus severity (n = 526)

IndicatorsMultivariable odds ratio (95% CI)P-value
Body temperature (°C)0.58 (0.45–0.74)<0.001
Pulse rate (beats/min)1.03 (1.01–1.05)<0.001
Crepitation3.25 (1.52–6.96)0.001
Lymphocyte (%)0.97 (0.95–0.98)0.001
AST (×10 IU/L)1.04 (1.02–1.06)<0.001
Serum albumin (g/dL)0.47 (0.27–0.80)0.001
Serum creatinine (mg/dL)1.83 (1.50–2.24)<0.001
Urine albumin*1.43 (1.17–1.75)<0.001

Note:

Represents urine albumin levels from negative to 4+.

Abbreviations: AST, aspartate aminotransferase; CI, confidence interval.

Discussion

The present study confirmed some clinical profiles related to scrub typhus severity.

Vital signs

The present study demonstrated that a decline of 1°C, and a more rapid pulse rate, increased the risk of severe scrub typhus. Hypothermia (body temperature below 36°C) and a pulse rate >90 beats per minute were consequences of systemic inflammatory response syndrome in patients with systemic infections, which led to septic shock in severe infection.16 Septic shock was reported as a common complication and risk of death in scrub typhus.3–5,17 In patients with septic shock, hypothermia was a significant risk factor for organ dysfunction and death, compared to those with fever.18

Physical examinations

The presence of crepitation was associated with scrub typhus severity in our study. Studies in the past all reported complications involving pulmonary systems, with 11%–54% of the cases resulting as a consequence of vasculitis and perivasculitis in the lungs.5,13,14,19–22 Chest X-rays showed interstitial infiltration, plural edema, pulmonary congestion, plural effusion, or cardiomegaly in 10%–64% of the cases.19–21,22 Patients may experience coughing or difficulty in breathing, and crepitation was reported in 23%–28% of pediatric patients15,23 and 30.7% of adults.4 More severe pulmonary involvement may present with acute respiratory distress syndrome and death.4

Percentage of lymphocytes

All previous studies mentioned elevated white blood cell counts in severe scrub typhus, but there were no reports addressing the percentage of lymphocytes.5,7,13,15 Some studies reported insignificant atypical lymphocytes in young scrub typhus patients.14,24 A study on the role of lymphocytes in scrub typhus reported early reduction of lymphocytes (mean ± standard deviation 24.49% ± 12.73%), which was explained as the shifting of peripheral lymphocytes into the infected tissues.25 The present study also reported a significant effect of the percentage of lymphocyte reduction. It may be inferred that antibiotics might be indicated, even in the absence of lymphocytosis.

Serum creatinine

Serum creatinine indicated impaired kidney function. Renal failure manifested by elevated serum creatinine was commonly reported in scrub typhus and may be life threatening.3,7,17,22 A study from India also reported serum creatinine >1.4 mg % as a risk predictor of death in scrub typhus.7

Aspartate aminotransferase

Elevated AST reflects hepatocellular involvement in most infectious diseases. In scrub typhus, 80% of the patients experienced significantly elevated AST.3,7,17,26,27 A study from Thailand in young scrub typhus patients reported 96.3% of patients with high AST. In patients with hepatic dysfunction, AST levels were as high as 197.7 ± 126.6 IU/L.26 The present study reported elevated AST (every 10 IU/L) as risk of severe scrub typhus.

Serum albumin

Patients with severe scrub typhus may have liver impairment causing a decline in albumin production. When associated with albumin leakages from blood vessels, as caused by vas-culitis, patients may develop severe hypoalbuminemia.13,17,26 However, a previous study reported no differences in mortality among patients with different albumin levels.28 In our study, a decline in serum albumin, as measured in g/dL, increased the risk of more severe scrub typhus, even after excluding patients with liver cirrhosis (data not shown).

Urine albumin

The presence of albumin in urine indicated renal pathology. Renal vasculitis, which causes leakage of albumin into the urine, was reported in scrub typhus patients with renal complications. Acute renal failure may cause shock; a study in Thailand reported septic shock in 88.9% of patients with positive urine albumin.17 In India, the corresponding figure was 28.6% in adults29 and 3%–17% in children.15,23 In the present study, higher levels of urine albumin significantly increased scrub typhus severity, even after excluding patients with diabetes, hypertension, and liver cirrhosis, all conditions in which positive urine albumin may already be present (data not shown). The most important limitation of this report was the fact that the diagnosis of scrub typhus was based on routine practice as recommended by the World Health Organization for medical resource limited developing countries, where the indirect immunofluorescence antibody test, or more standard (and more complex) methods, were not readily available. Scrub typhus in this study, therefore, was actually suspected scrub typhus according to the World Health Organization’s definition; however, we, the authors, believe that this is the more realistic situation currently occurring in poor developing countries.

Conclusion

Patients suspicious of scrub typhus with low body temperature, rapid pulse rate, crepitation, low percentage of lymphocytes, low serum albumin, elevated AST, elevated serum creatinine, and positive urine albumin may be at risk for more severe scrub typhus. Clinicians encountering such patients should be aware of disease progression to more severe states, and might consider early investigation or monitoring for systemic involvement to reduce or avoid further complications and death.
  23 in total

1.  Scrub typhus: chest radiographic and clinical findings in 130 Thai patients.

Authors:  A Charoensak; O Chawalparit; C Suttinont; K Niwattayakul; K Losuwanaluk; S Silpasakorn; Y Suputtamongkol
Journal:  J Med Assoc Thai       Date:  2006-05

2.  Rapid diagnosis of scrub typhus in rural Thailand using polymerase chain reaction.

Authors:  Piengchan Sonthayanon; Wirongrong Chierakul; Vanaporn Wuthiekanun; Stuart D Blacksell; Kriangsak Pimda; Yupin Suputtamongkol; Sasithon Pukrittayakamee; Nicholas J White; Nicholas P Day; Sharon J Peacock
Journal:  Am J Trop Med Hyg       Date:  2006-12       Impact factor: 2.345

3.  Scrub typhus among hospitalised patients with febrile illness in South India: magnitude and clinical predictors.

Authors:  G M Varghese; O C Abraham; D Mathai; K Thomas; R Aaron; M L Kavitha; E Mathai
Journal:  J Infect       Date:  2006-01       Impact factor: 6.072

Review 4.  Diagnosis of scrub typhus.

Authors:  Gavin C K W Koh; Richard J Maude; Daniel H Paris; Paul N Newton; Stuart D Blacksell
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

5.  Scrub typhus: an unrecognized threat in South India - clinical profile and predictors of mortality.

Authors:  Anugrah Chrispal; Harikishan Boorugu; Kango Gopal Gopinath; John Antony Jude Prakash; Sara Chandy; O C Abraham; Asha Mary Abraham; Kurien Thomas
Journal:  Trop Doct       Date:  2010-04-01       Impact factor: 0.731

6.  Scrub typhus in children at a tertiary hospital in southern India: clinical profile and complications.

Authors:  Manish Kumar; Sriram Krishnamurthy; C G Delhikumar; Parameswaran Narayanan; Niranjan Biswal; Sadagopan Srinivasan
Journal:  J Infect Public Health       Date:  2011-12-24       Impact factor: 3.718

Review 7.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Intensive Care Med       Date:  2003-03-28       Impact factor: 17.440

8.  Epidemiology and clinical aspects of rickettsioses in Thailand.

Authors:  Y Suputtamongkol; C Suttinont; K Niwatayakul; S Hoontrakul; R Limpaiboon; W Chierakul; K Losuwanaluk; W Saisongkork
Journal:  Ann N Y Acad Sci       Date:  2009-05       Impact factor: 5.691

9.  Acute respiratory distress syndrome in scrub typhus.

Authors:  Chin-Chou Wang; Shih-Feng Liu; Jien-Wei Liu; Yu-Hsiu Chung; Mao-Chang Su; Meng-Chih Lin
Journal:  Am J Trop Med Hyg       Date:  2007-06       Impact factor: 2.345

10.  Clinical significance of hypoalbuminemia in outcome of patients with scrub typhus.

Authors:  Chang-Seop Lee; In-Suk Min; Jeong-Hwan Hwang; Keun-Sang Kwon; Heung-Bum Lee
Journal:  BMC Infect Dis       Date:  2010-07-21       Impact factor: 3.090

View more
  9 in total

1.  Predictors of Severity in Pediatric Scrub Typhus.

Authors:  Dinesh Kumar Narayanasamy; Thirunavukkarasu Arun Babu; Vijayasankar Vijayadevagaran; Devi Kittu; Shanthi Ananthakrishnan
Journal:  Indian J Pediatr       Date:  2018-01-24       Impact factor: 1.967

2.  The Applicability of Commonly Used Severity of Illness Scores to Tropical Infections in Australia.

Authors:  Kris Salaveria; Simon Smith; Yu-Hsuan Liu; Richard Bagshaw; Markus Ott; Alexandra Stewart; Matthew Law; Angus Carter; Josh Hanson
Journal:  Am J Trop Med Hyg       Date:  2021-10-18       Impact factor: 3.707

3.  Validation of a clinical risk-scoring algorithm for severe scrub typhus.

Authors:  Pamornsri Sriwongpan; Jayanton Patumanond; Pornsuda Krittigamas; Hutsaya Tantipong; Chamaiporn Tawichasri; Sirianong Namwongprom
Journal:  Risk Manag Healthc Policy       Date:  2014-02-18

4.  Eschar is associated with poor prognosis in scrub typhus.

Authors:  Vivek Chauhan; Anurag Thakur; Suman Thakur
Journal:  Indian J Med Res       Date:  2017-05       Impact factor: 2.375

5.  Clinical Score to Differentiate Scrub Typhus and Dengue: A Tool to Differentiate Scrub Typhus and Dengue.

Authors:  Shubhanker Mitra; Ira Gautam; Mohan Jambugulam; Kundavaram Paul Prabhakar Abhilash; Vishalakshi Jayaseeelan
Journal:  J Glob Infect Dis       Date:  2017 Jan-Mar

Review 6.  Scrub typhus: risks, diagnostic issues, and management challenges.

Authors:  John Antony Jude Prakash
Journal:  Res Rep Trop Med       Date:  2017-08-07

7.  Clinical significance of abnormal chest radiographic findings for acute kidney injury in patients with scrub typhus.

Authors:  Hyun Ju Yang; Sung-Min Kim; Jin Sol Choi; Ju Hwan Oh; A Young Cho; Mi Sook Lee; Kwang Young Lee; In O Sun
Journal:  Kidney Res Clin Pract       Date:  2020-03-31

8.  A time-course comparative clinical and immune response evaluation study between the human pathogenic Orientia tsutsugamushi strains: Karp and Gilliam in a rhesus macaque (Macaca mulatta) model.

Authors:  Manutsanun Inthawong; Piyanate Sunyakumthorn; Sirima Wongwairot; Tippawan Anantatat; Susanna J Dunachie; Rawiwan Im-Erbsin; James W Jones; Carl J Mason; Luis A Lugo; Stuart D Blacksell; Nicholas P J Day; Piengchan Sonthayanon; Allen L Richards; Daniel H Paris
Journal:  PLoS Negl Trop Dis       Date:  2022-08-04

9.  The temporal dynamics of humoral immunity to Rickettsia typhi infection in murine typhus patients.

Authors:  K Phakhounthong; M Mukaka; S Dittrich; A Tanganuchitcharnchai; N P J Day; L J White; P N Newton; S D Blacksell
Journal:  Clin Microbiol Infect       Date:  2019-10-31       Impact factor: 8.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.